Clinical Trial Update: RTMS for the Treatment of Post-COVID Associated Affective Symptoms [NA]

View source ↗

Summary

A clinical trial is evaluating repetitive transcranial magnetic stimulation (RTMS) as a treatment for Post-COVID-19 depression and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-covid-19 Depression

Drugs mentioned

• repetitive transcranial magnetic stimulation (rTMS)

Snippet

Sponsor: Flurin Cathomas | Conditions: Post COVID -19 Depression | NA | Status: RECRUITING